DABXIGA 110MG CAPSULE belongs to a class of drugs known as anticoagulants or blood thinners used to prevent and treat the risk of stroke, and heart attack in patients with atrial fibrillation (irregular heart rhythm), reducing blood clot formation. Besides this, it is also used to prevent deep vein thrombosis (blood clots in leg veins) and pulmonary embolism (blood clots in the lung) and reduces the risk of getting clots in people who have undergone knee or hip replacement surgeries.

DABXIGA 110MG CAPSULE contains ‘Dabigatran’, which works by inhibiting the production of clotting factors Xa called thrombin. This prevents the conversion of fibrinogen (soluble protein) to fibrin (insoluble protein), thereby preventing blood clot formation. It makes your blood flow easy through your veins, making it less likely to form a serious blood clot. So, an intake of DABXIGA 110MG CAPSULE helps prevent blood clots if you have an increased risk of having a heart attack, or stroke.

Take DABXIGA 110MG CAPSULE as prescribed by your doctor. You are advised to take DABXIGA 110MG CAPSULE for as long as your doctor has prescribed it for you, depending on your medical conditions. You may experience bleeding, anaemia (low number of red blood cells), and nausea, stomach pain, indigestion. Most of these side effects of DABXIGA 110MG CAPSULE do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.

If you are known to be allergic to DABXIGA 110MG CAPSULE or any other medicines, please tell your doctor. If you are pregnant or breastfeeding, it is advised to consult a doctor before using DABXIGA 110MG CAPSULE . If you have a stomach ulcer, kidney or liver problems, high blood pressure, or bleeding problems, inform your doctor before taking DABXIGA 110MG CAPSULE . Try not to stop taking this medicine of your own. Stopping a sudden intake of DABXIGA 110MG CAPSULE may worsen your condition and increase your risk of cardiovascular death, heart attack, and stroke.

DABXIGA 110MG CAPSULE belongs to a class of drugs known as anticoagulants or blood thinner. It prevents clot formation in the deep vein thrombosis (veins of the legs), pulmonary embolism (lungs), stroke (brain), and heart in patients with atrial fibrillation (irregular heart rhythm). DABXIGA 110MG CAPSULE is primarily used to prevent and treat the risk of stroke and heart attack by reducing blood clot formation. Besides this, it also reduces the risk of getting clots in people who have undergone knee or hip replacement surgeries. DABXIGA 110MG CAPSULE works by stopping the action of clotting factor (thrombin). This prevents the conversion of fibrinogen (soluble protein) to fibrin (insoluble protein), thereby preventing blood clots formation.

If you are known to be allergic to DABXIGA 110MG CAPSULE or any other medicines, please tell your doctor. If you are pregnant or breastfeeding, it is advised to consult a doctor before using DABXIGA 110MG CAPSULE . Safety and effectiveness of DABXIGA 110MG CAPSULE have not been established, so its use should be avoided in pediatric patients or children less than 18 years of age. If you have a stomach ulcer, kidney or liver problems, high blood pressure, or bleeding problems, inform your doctor before taking DABXIGA 110MG CAPSULE . Try not to stop taking DABXIGA 110MG CAPSULE of your own. Stopping a sudden intake of DABXIGA 110MG CAPSULE may worsen your condition and increase your risk of cardiovascular death, heart attack, and stroke. Hence, you should consult a doctor before stopping the dose of DABXIGA 110MG CAPSULE . You should inform the doctor that you are taking DABXIGA 110MG CAPSULE before any surgery is scheduled. DABXIGA 110MG CAPSULE can cause a serious blood clot around your spinal cord if you undergo a spinal tap or receive spinal anesthesia (epidural). Avoid consumption of alcohol while taking DABXIGA 110MG CAPSULE as it may increase the risk of stomach bleeding.

You should have regular platelet count, factor V assay, fibrinogen level test, prothrombin time test (PT or PT-INR), and the INR, or international normalized ratio to analyze your blood clotting time.